valsartan


Also found in: Thesaurus, Medical, Wikipedia.

val·sar·tan

 (văl-sär′tn)
n.
An angiotensin II receptor blocker drug, C24H29N5O3, used to treat hypertension and heart failure.

[val(ine) + -sartan, angiotensin II receptor blocker suff.; see losartan.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.valsartan - an angiotensin II inhibitor that is used to treat high blood pressure
angiotensin II inhibitor - an agent that retards or restrains the action of angiotensin II
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

valsartan

n valsartán m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Novartis has been testing the safety and efficacy of Entrestro, made up of sacubitril and valsartan, compared to just valsartan in patients with heart failure.
The randomized, double-blind, Phase III outcome study evaluated the long-term efficacy and safety profile of Entresto against an active comparator (valsartan) in HFpEF[8].
The latestA recall affected losartan (Cozaar), valsartan (Diovan and Prexxartan) and irbesartan (Avapro).A ARBs are known for helping reduce blood pressure.
Novartis announced topline results from the global Phase III PARAGON-HF study, investigating the safety and efficacy of sacubitril/valsartan versus the active comparator valsartan in HFpEF patients.
The discovery that some generic versions of these drugs (valsartan, losartan, and irbesartan) contained potentially harmful impurities has led to widespread recalls.
A solvent called dimethylformamide was discovered in the drug valsartan made by several companies, including Swiss pharmaceutical giant Novartis, according to a filing last week to the Food and Drug Administration by New Haven, Connecticut-based Valisure.
The lawsuits are centered around Zhejiang Huahai Pharmaceutical Co., which distributed the contaminated Valsartan as a blood pressure medication and as a cardiovascular treatment for patients, Bloomberg reported.
In July 2018, the board also issued a statement on an ingredient called valsartan used in generic medicines to treat high blood pressure.
M2 PHARMA-March 13, 2019-US FDA approves new generic valsartan for high blood pressure and heart failure
Global Banking News-March 13, 2019-US FDA approves new generic valsartan for high blood pressure and heart failure
M2 EQUITYBITES-March 13, 2019-US FDA approves new generic valsartan for high blood pressure and heart failure